Literature DB >> 18979183

Preimplantation genetic diagnosis: does age of onset matter (anymore)?

Timothy Krahn1.   

Abstract

The identification and avoidance of disease susceptibility in embryos is the most common goal of preimplantation genetic diagnosis (PGD). Most jurisdictions that accept but regulate the availability of PGD restrict it to what are characterized as 'serious' conditions. Line-drawing around seriousness is not determined solely by the identification of a genetic mutation. Other factors seen to be relevant include: impact on health or severity of symptoms; degree of penetrance (probability of genotype being expressed as a genetic disorder); potential for therapy; rate of progression; heritability; and age of onset. In the original applications of PGD, most, if not all of these factors were seen as necessary but none was seen as sufficient for determining whether a genetic condition was labelled 'serious'. This, however, is changing as impact on health or severity of symptoms is coming to eclipse the other considerations. This paper investigates how age of onset (primarily in the context of the United Kingdom (UK)) has become considerably less significant as a criterion for determining ethically acceptable applications of PGD. Having moved off the threshold of permitting PGD testing for only fatal (or seriously debilitating), early-onset diseases, I will investigate reasons for why age of onset will not do any work to discriminate between which adult-onset diseases should be considered serious or not. First I will explain the rationale underpinning age of onset as a factor to be weighed in making determinations of seriousness. Next I will challenge the view that later-onset conditions are less serious for being later than earlier-onset conditions. The final section of the paper will discuss some of the broader disability concerns at stake in limiting access to PGD based upon determinations of the 'seriousness' of genetic conditions. Instead of advocating a return to limiting PGD to only early-onset conditions, I conclude that the whole enterprise of trying to draw lines of what is to count as a 'serious' condition is itself problematic and in certain ways morally misleading.

Entities:  

Mesh:

Year:  2008        PMID: 18979183     DOI: 10.1007/s11019-008-9171-x

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  57 in total

1.  Preimplantation genetic diagnosis and the 'new' eugenics.

Authors:  D S King
Journal:  J Med Ethics       Date:  1999-04       Impact factor: 2.903

2.  A choice of evils in prenatal testing.

Authors:  David Wasserman
Journal:  Fla State Univ Law Rev       Date:  2003

3.  Psychological distress of parents of infants with Down syndrome.

Authors:  B S Scott; L Atkinson; H L Minton; T Bowman
Journal:  Am J Ment Retard       Date:  1997-09

4.  ESHRE PGD Consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004.

Authors:  K D Sermon; A Michiels; G Harton; C Moutou; S Repping; P N Scriven; S SenGupta; J Traeger-Synodinos; K Vesela; S Viville; L Wilton; J C Harper
Journal:  Hum Reprod       Date:  2006-11-28       Impact factor: 6.918

5.  The disability paradox: high quality of life against all odds.

Authors:  G L Albrecht; P J Devlieger
Journal:  Soc Sci Med       Date:  1999-04       Impact factor: 4.634

6.  PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis.

Authors:  Andrea L Kalfoglou; Joan Scott; Kathy Hudson
Journal:  Reprod Biomed Online       Date:  2005-10       Impact factor: 3.828

7.  Serious genetic disorders: can or should they be defined?

Authors:  Dorothy C Wertz; Bartha Maria Knoppers
Journal:  Am J Med Genet       Date:  2002-02-15

8.  Extending preimplantation genetic diagnosis: medical and non-medical uses.

Authors:  J A Robertson
Journal:  J Med Ethics       Date:  2003-08       Impact factor: 2.903

9.  Huntington's disease: prenatal screening for late onset disease.

Authors:  S G Post
Journal:  J Med Ethics       Date:  1992-06       Impact factor: 2.903

10.  UK clinicians' knowledge of and attitudes to the prenatal diagnosis of single gene disorders.

Authors:  H V Firth; R H Lindenbaum
Journal:  J Med Genet       Date:  1992-01       Impact factor: 6.318

View more
  6 in total

Review 1.  A new era in clinical genetic testing for hypertrophic cardiomyopathy.

Authors:  Matthew Wheeler; Aleksandra Pavlovic; Emil DeGoma; Heidi Salisbury; Colleen Brown; Euan A Ashley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-30       Impact factor: 4.132

2.  "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.

Authors:  Marleah Dean; Emily A Rauscher
Journal:  J Genet Couns       Date:  2017-01-30       Impact factor: 2.537

Review 3.  A systematic review of the views of healthcare professionals on the scope of preimplantation genetic testing.

Authors:  Maria Siermann; Zoë Claesen; Laurent Pasquier; Taneli Raivio; Olga Tšuiko; Joris Robert Vermeesch; Pascal Borry
Journal:  J Community Genet       Date:  2022-01-14

4.  Acceptable applications of preimplantation genetic diagnosis (PGD) among Israeli PGD users.

Authors:  Shachar Zuckerman; David A Zeevi; Sigal Gooldin; Gheona Altarescu
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

5.  A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions.

Authors:  Tara Clancy
Journal:  Fam Cancer       Date:  2009-07-31       Impact factor: 2.375

6.  In vitro fertilisation with preimplantation genetic testing: the need for expanded insurance coverage.

Authors:  Madison K Kilbride
Journal:  J Med Ethics       Date:  2020-08-19       Impact factor: 2.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.